Concepedia

Michelle McGreevy

MM

Statistics

Publications

3

Citations

267

H-Index

3

Active since

2006

Affiliations

Cleveland Clinic(Current)

Johnson & Johnson (United States)

University of Southern California

Institute of Oncology Ljubljana

Radboud University Nijmegen

Michelle McGreevy is an author at Cleveland Clinic specializing in adjuvant hormonal therapy, genetics, and oncology.

Publications per year

2006–2009

3

Publications

3

The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy

Yi Zhang, Anieta M. Sieuwerts, Michelle McGreevy et al. · Breast Cancer Research and Treatment · 2008 · 156 citations · Full text

, , +12

Podocalyxin variants and risk of prostate cancer and tumor aggressiveness

Graham Casey, Phillippa J. Neville, Xin Liu et al. · Human Molecular Genetics · 2006 · 95 citations · Full text

, , +17

The 76-Gene Signature Defines High-Risk Patients That Benefit from Adjuvant Tamoxifen Therapy.

Y. Zhang, Anieta M. Sieuwerts, Michelle McGreevy et al. · Cancer Research · 2009 · 16 citations

, , +15

1–3 of 3